Stock CNTG CENTOGENE N.V.
Add to a list
To use this feature you must be a member
Log inSign up

News Centogene N.V.

Equities

CNTG

NL0014040206

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
0.3806 USD +2.86% Intraday chart for Centogene N.V. -4.83% -68.28%
May. 16 Upcoming Slew of Economic Data Buoys Exchange-Traded Funds, Equity Futures Pre-Bell Thursday MT
May. 16 Top Premarket Gainers MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Upcoming Slew of Economic Data Buoys Exchange-Traded Funds, Equity Futures Pre-Bell Thursday
MT
Top Premarket Gainers
MT
Centogene N : KSA RECEIVABLES TRANSFER AGREEMENT - Form 6-K
PU
CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
GL
Centogene N.V. Provides Earnings Guidance for the Year 2024
CI
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position
GL
Centogene N : Voting Proxy AGM 2024
PU
Centogene N : Convening Notice and Agenda (incl. explanatory notes) (AGM 2024)
PU
Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment
MT
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
GL
Centogene N.V and Evotec SE Discovers Promising New Molecule to Treat Gaucher Disease
CI
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
AQ
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
GL
Centogene Biodatabank Grows to Incorporate Disease Insights from over 850,000 Diverse Patients
CI
Centogene N : Form 6-K
PU
Centogene Gets Nasdaq Noncompliance Notice
MT
CENTOGENE Receives Nasdaq Non-Compliance Notice
GL
Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics
MT
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
GL
Centogene N.V. Announces the Extension of an Ongoing Partnership with Takeda to Continue Providing Access to Genetic Testing for Patients with Lysosomal Storage Disorders
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CNTG Stock
  4. News Centogene N.V.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW